With box warnings

Without box warnings

Branded

Generic

2 results

imfinzi
(Durvalumab)
AstraZeneca Pharmaceuticals LP
Usage: IMFINZI is indicated for various cancers, including resectable non-small cell lung cancer (NSCLC), unresectable Stage III NSCLC, small cell lung cancer (SCLC), biliary tract cancer, hepatocellular carcinoma, advanced or recurrent endometrial cancer, and muscle invasive bladder cancer in combination with other treatments.
jemperli
(dostarlimab)
GlaxoSmithKline LLC
Usage: JEMPERLI is indicated for adults with primary advanced or recurrent endometrial cancer (EC) in combination with carboplatin and paclitaxel, followed by JEMPERLI alone. It also treats adults with mismatch repair deficient recurrent or advanced solid tumors that have progressed after prior treatment and lack satisfactory alternatives.

Medications for Malignant Neoplasm Of Endometrium

imfinzi